ドラベ症候群の自然経過を2年間追跡した前向き研究結果を発表 バイオジェン、ストーク・セラピューティクス社2025-11-27
Medical Tribune,
バイオジェンとストーク・セラピューティクス社は昨日（11月26日）、ドラベ症候群患者の自然経過を2年間追跡した前向き研究BUTTERFLY試験の最終データをNeurology（2025; 105: e214388）に発表したと発表した。（関連記事「ドラベ症候…
News story from Finanz Nachrichten on Monday 17 November 2025
Finanz Nachrichten,
Biogen and Stoke Therapeutics Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments
Futures TradingCharts.com,
- Despite treatment with standard-of-care anti-seizure medicines, children with Dravet syndrome experienced high seizure burden…
Biogen and Stoke Therapeutics Announce Publication of Two-Year Natural History Data Demonstrating the Severity of Dravet Syndrome, Including Frequent Seizures and Significant Cognitive and Behavioral Impairments
Stockwatch,
– Despite treatment with standard-of-care anti-seizure medicines, children with Dravet syndrome experienced high seizure burden…